2022 ASCO Annual Meeting*

Download All
June 3-7, 2022; Chicago, Illinois
Expert faculty review and share their insights and perspectives on key findings in skin cancers presented at the 2022 ASCO Annual Meeting.
Allison Betof Warner, MD, PhD
Hussein Tawbi, MD, PhD

Skin Cancer

Slidesets Tebentafusp ± Durvalumab and/or Tremelimumab in Metastatic Cutaneous Melanoma: Updated OS Analysis From IMCgp100-201 Trial
Slidesets PRADO: Phase II Trial of Response-Directed Surgery and Adjuvant Therapy Following Neoadjuvant Ipilimumab and Nivolumab in Stage III Melanoma
Slidesets SWOG 1512: Phase II Study of Neoadjuvant Pembrolizumab in Patients With Resectable Desmoplastic Melanoma
Slidesets NeoTrio: Neoadjuvant Pembrolizumab Alone, Combined With, or in Sequence With Dabrafenib and Trametinib in Resectable BRAFV600-Mutant Stage III Melanoma
Slidesets RELATIVITY-047: OS and ORR by Key Subgroups in Patients With Advanced Melanoma Receiving First-line Relatlimab + Nivolumab vs Nivolumab Alone
Slidesets First-line Camrelizumab, Apatinib, and Temozolomide in Advanced Acral Melanoma
Slidesets AMBER Parts 1C and 1E: Phase I Trial of Cobolimab, an Anti–TIM-3 mAb, Plus Dostarlimab in Advanced Melanoma
Slidesets TRICOTEL: Phase II Study of Atezolizumab, Cobimetinib, and Vemurafenib in BRAFV600-Mutated Melanoma With CNS Metastases
Slidesets CheckMate 067: Long-term Survival and HRQoL With First-line Nivolumab ± Ipilimumab in Advanced Melanoma at 7.5-Yr Follow-up
Slidesets KEYNOTE-716: Update of the Phase III Trial of Adjuvant Pembrolizumab vs Placebo in Stage IIB/IIC Melanoma

Review expert perspectives on the most clinically relevant data on skin cancers presented at the 2022 ASCO Annual Meeting.

Allison Betof Warner, MD, PhD Hussein Tawbi, MD, PhD Physicians: maximum of 1.0 AMA PRA Category 1 Credit™ Released: August 29, 2022 Expired: August 28, 2023
Provided by Clinical Care Options, LLC
Contact Info

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Supported by educational grants from
Bristol-Myers Squibb
Merck Sharp & Dohme Corp.

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Cookie Settings